BIB - ProShares Ultra Nasdaq Biotechnology
| Previous Close | 49.39 |
| Open | 50.41 |
| Bid | 49.66 x 800 |
| Ask | 50.50 x 800 |
| Day's Range | 48.65 - 51.10 |
| 52 Week Range | 46.69 - 70.82 |
| Volume | 126,979 |
| Avg. Volume | 187,757 |
| Net Assets | 316.23M |
| NAV | 54.52 |
| PE Ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD Return | -2.91% |
| Beta (3Y Monthly) | 3.44 |
| Expense Ratio (net) | 0.95% |
| Inception Date | 2010-04-06 |
- Investor's Business Daily•2 months ago
Swing Trade In Biotech Sector Gave The Best Of Both Worlds
Stocks in the biotech sector pose a problem for a swing trade. We take profits quicker, so we need to avoid big losses. Biotech stocks make that difficult.
- Market Realist•3 months ago
Major Biotech ETFs Had Lackluster Performance in the Past Month
All three major biotechnology ETFs—the SPDR S&P Biotech ETF (XBI), the iShares NASDAQ Biotechnology Index (IBB), and the ProShares Ultra Nasdaq Biotechnology ETF (BIB)—have posted returns of ~1% in last month, starting on August 10. That compares unfavorably with the performance of the SPDR S&P 500 ETF (SPY), which returned ~1.7% in the same period.
- Investor's Business Daily•6 months ago
Biotech Funds Tacked On $76 Million This Week — Are They Recovering?
Biotech funds tacked on $76 million this week, adding to more than $500 million in net inflows over the past two weeks — a phenomenon the group hasn't seen in nine months.
Yahoo Finance•11 months agoBayer and J&J win big, Microsoft lags because of Intel, Apple turns over information
Johnson & Johnson, Microsoft, Apple and Toyota are the companies to watch.
